CPB Stock Analysis: Campbell’s | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 6.757m USD | 12M Return: -23.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 212M
EPS Trend: -60.4%
Qual. Beats: 0
Rev. Trend: 83.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Campbells Company (NASDAQ: CPB) is a U.S.-based packaged food manufacturer operating through two segments: Meals & Beverages, and Snacks. The Meals & Beverages segment sells soups, broths, sauces, juices, and frozen entrées under brands such as Campbells, Swanson, Pacific Foods, Prego, Pace, V8, Raos, and Michael Angelos, primarily in the U.S. and Canada. The Snacks segment markets cookies, crackers, pretzels, and chips through brands including Pepperidge Farm, Goldfish, Snyders of Hanover, Lance, Cape Cod, Kettle Brand, and Late July, with additional retail operations in Latin America.
Products are distributed through retail food chains, mass discounters, club stores, convenience and dollar stores, e-commerce platforms, and foodservice operators, as well as via independent contractor distributors. The company was founded in 1869, is headquartered in Camden, New Jersey, and rebranded from Campbell Soup Company to The Campbells Company in November 2024.
As a mid-cap stock in the Packaged Foods & Meats sub-industry of Consumer Staples, Campbells operates in a defensive sector characterized by relatively stable consumer demand and brand-driven pricing, with revenue split between retail shelf-stable products and higher-margin snacking categories.
- Raos premium pasta sauce sales accelerate post-Sovos acquisition
- Snacks segment volume softens as center-store demand normalizes
- Input cost inflation and acquisition debt pressure profit margins
| Net Income: 608.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.05 > 1.0 |
| NWC/Revenue: -3.98% < 20% (prev -6.09%; Δ 2.11% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.10b > Net Income 608.0m |
| Net Debt (7.03b) to EBITDA (1.53b): 4.58 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (299.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 28.85% > 18% (prev 30.21%; Δ -1.36% > 0.5%) |
| Asset Turnover: 66.25% > 50% (prev 68.96%; Δ -2.70% > 0%) |
| Interest Coverage Ratio: 3.39 > 6 (EBIT TTM 1.12b / Interest Expense TTM 331.0m) |
| A: -0.03 (Total Current Assets 2.56b - Total Current Liabilities 2.95b) / Total Assets 15.1b |
| B: 0.32 (Retained Earnings 4.80b / Total Assets 15.1b) |
| C: 0.07 (EBIT TTM 1.12b / Avg Total Assets 15.0b) |
| D: 0.36 (Book Value of Equity 4.03b / Total Liabilities 11.1b) |
| Altman-Z'' = 1.75 = BBB |
| DSRI: 0.85 (Receivables 552.0m/668.0m, Revenue 9.93b/10.2b) |
| GMI: 1.05 (GM 30.21% / 28.85%) |
| AQI: 0.97 (AQ_t 0.65 / AQ_t-1 0.67) |
| SGI: 0.97 (Revenue 9.93b / 10.2b) |
| TATA: -0.03 (NI 608.0m - CFO 1.10b) / TA 15.1b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of July 13, 2026, the stock is trading at USD 22.07 with a total of 4,946,063 shares traded. Over the past week, the price has changed by -5.36%, over one month by -1.61%, over three months by +11.27% and over the past year by -23.57%.
Current recommended Stop Loss: 20.60 (which is 6.7% or 1.7 ATR below the current price).
Campbell’s has received a consensus analysts rating of 2.84. Therefore, it is recommended to hold CPB.
- StrongBuy: 2
- Buy: 0
- Hold: 12
- Sell: 3
- StrongSell: 2
| Analysts Target Price | 21.5 | -2.7% |
P/E Trailing = 11.1078
P/E Forward = 11.2486
P/S = 0.6806
P/B = 1.7279
P/EG = 0.7757
Revenue TTM = 9.93b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.53b USD
Long Term Debt = 6.15b USD (from longTermDebt, last quarter)
Short Term Debt = 864.0m USD (from shortTermDebt, last quarter)
Debt = 7.43b USD (from shortLongTermDebtTotal, last quarter) + Leases 425.0m
Net Debt = 7.03b USD (calculated: Debt 7.43b - CCE 402.0m)
Enterprise Value = 13.8b USD (6.76b + Debt 7.43b - CCE 402.0m)
Interest Coverage Ratio = 3.39 (Ebit TTM 1.12b / Interest Expense TTM 331.0m)
EV/FCF = 15.36x (Enterprise Value 13.8b / FCF TTM 898.0m)
FCF Yield = 6.51% (FCF TTM 898.0m / Enterprise Value 13.8b)
FCF Margin = 9.05% (FCF TTM 898.0m / Revenue TTM 9.93b)
Net Margin = 6.12% (Net Income TTM 608.0m / Revenue TTM 9.93b)
Gross Margin = 28.85% ((Revenue TTM 9.93b - Cost of Revenue TTM 7.06b) / Revenue TTM)
Gross Margin QoQ = 27.47% (prev 27.96%)
Tobins Q-Ratio = 0.91 (Enterprise Value 13.8b / Total Assets 15.1b)
Interest Expense / Debt = 4.45% (Interest Expense 331.0m / Debt 7.43b)
Taxrate = 23.23% (184.0m / 792.0m)
NOPAT = 862.1m (EBIT 1.12b * (1 - 23.23%))
Current Ratio = 0.87 (Total Current Assets 2.56b / Total Current Liabilities 2.95b)
Debt / Equity = 1.85 (Debt 7.43b / totalStockholderEquity, last quarter 4.03b)
Debt / EBITDA = 4.58 (Net Debt 7.03b / EBITDA 1.53b)
Debt / FCF = 7.83 (Net Debt 7.03b / FCF TTM 898.0m)
Total Stockholder Equity = 3.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.06% (Net Income 608.0m / Total Assets 15.1b)
RoE = 15.30% (Net Income TTM 608.0m / Total Stockholder Equity 3.97b)
RoCE = 11.10% (EBIT 1.12b / Capital Employed (Equity 3.97b + L.T.Debt 6.15b))
RoIC = 6.82% (NOPAT 862.1m / Invested Capital 12.7b)
WACC = 4.46% (E(6.76b)/V(14.2b) * Re(5.61%) + D(7.43b)/V(14.2b) * Rd(4.45%) * (1-Tc(0.23)))
Discount Rate = 5.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.17 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈828.0m ; Y1≈949.2m ; Y5≈1.40b
[DCF] Fair Price = 46.91 (EV 21.0b - Net Debt 7.03b = Equity 14.0b / Shares 298.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -60.42 | EPS CAGR: -4.73% | SUE: 0.50 | # QB: 0
Revenue Correlation: 83.95 | Revenue CAGR: 3.71% | SUE: -0.46 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.62 | Chg30d=-10.11% | Revisions=-81% | Analysts=13
EPS current Year (2026-07-31): EPS=2.17 | Chg30d=+0.01% | Revisions=-32% | GrowthEPS=-26.8% | GrowthRev=-4.8%
EPS next Year (2027-07-31): EPS=1.97 | Chg30d=-7.43% | Revisions=-85% | GrowthEPS=-9.2% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: -73% (up=5, down=41)